Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2011 Jul;77(13):4422–4428. doi: 10.1128/AEM.00554-11

The Histone-Like Protein Hlp Is Essential for Growth of Streptococcus pyogenes: Comparison of Genetic Approaches To Study Essential Genes

Julia V Bugrysheva 1,, Barbara J Froehlich 1,, Jeffrey A Freiberg 1, June R Scott 1,*
PMCID: PMC3127713  PMID: 21531823

Abstract

Selection of possible targets for vaccine and drug development requires an understanding of the physiology of bacterial pathogens, for which the ability to manipulate expression of essential genes is critical. For Streptococcus pyogenes (the group A streptococcus [GAS]), an important human pathogen, the lack of genetic tools for such studies has seriously hampered research. To address this problem, we characterized variants of the inducible Ptet cassette, in both sense and antisense contexts, as tools to regulate transcription from GAS genes. We found that although the three-operator Ptet construct [Ptet(O)3] had low uninduced expression, its induction level was low, while the two-operator construct [Ptet(O)2] was inducible to a high level but showed significant constitutive expression. Use of Ptet(O)3 in the chromosome allowed us to demonstrate previously that RNases J1 and J2 are required for growth of GAS. Here we report that the uninduced level from the chromosomally inserted Ptet(O)2 construct was too high for us to observe differential growth. For the highly expressed histone-like protein (Hlp) of GAS, neither chromosomal insertion of Ptet(O)2 or Ptet(O)3 nor their use on a high-copy-number plasmid to produce antisense RNA specific to hlp resulted in adequate differential expression. However, by replacing the ribosome binding site of hlp with an engineered riboswitch to control translation of Hlp, we demonstrated for the first time that this protein is essential for GAS growth.

INTRODUCTION

Streptococcus pyogenes (the group A streptococcus [GAS]) is a Gram-positive, exclusively human pathogen. GAS produces a wide range of diseases, including superficial infections of the skin (impetigo) and throat (pharyngitis) and severe invasive infections (necrotizing fasciitis and toxic shock syndrome) (7, 31, 40). In some individuals, superficial GAS infections can also lead to complications that involve the immune system (glomerulonephritis and acute rheumatic fever) (7). Although GAS currently remains sensitive to penicillin, the rate of penicillin treatment failure is as high as 37% (23, 33), and allergy to this antibiotic precludes its use in many people (32). Therefore, GAS remains a major public health problem, with an estimated toll of over 500,000 deaths each year worldwide (6) and an annual estimated cost of over $1 billion. To reduce this disease burden, prevention of infection is desirable. Development of appropriate therapeutic interventions and of vaccines to prevent infection requires an understanding of the physiology of the bacterial pathogen. Although genetic analyses of GAS have progressed extensively in the last few years and many tools for study of GAS are now available, until recently there have been no suitable techniques for studying genes essential for growth of GAS, although such genes are obviously appropriate therapeutic targets.

For studies of the functions of essential genes, a promoter that can be regulated under laboratory conditions would be helpful. In GAS, the regulated promoter that has been employed previously is the nisin-inducible lactococcal PnisA promoter (11), which requires the additional introduction into the strain to be studied of nisR and nisK, the two-component system that controls expression from PnisA in response to exogenously added nisin (24). Although induction of this promoter in GAS by nisin is about 10-fold, the background level of expression is high. Furthermore, nisin is bactericidal to GAS, and the appropriate concentration for its use as an inducer varies with the strain studied (11). Thus, this system has not been employed extensively for work with GAS.

In many organisms, including several Gram-positive bacteria, modifications of the tetracycline-inducible promoter Ptet, which is based on the promoter of Tn10 from Escherichia coli, can be employed for conditional expression of genes (14). In this system, the tet repressor, TetR, controls expression (18). In the absence of an inducer, TetR binds to the tet operator tetO, a 19-nucleotide (nt) palindromic sequence that overlaps the promoter for the regulated gene, to prevent expression of this gene. When an inducer is present, it binds to TetR, releasing it from the operator and allowing expression of the regulated gene.

The tetracycline-inducible system was adapted from the Gram-negative bacterium E. coli for the Gram-positive bacterium Bacillus subtilis by (i) inserting poly(A) blocks upstream of tetO, (ii) altering the promoter sequence to increase its strength for B. subtilis, and (iii) replacing the tetR ribosome-binding site (RBS) with a strong consensus RBS (AGGAGG) (14). The tet system adapted for Gram-positive bacteria comprises tetR, with its RBS, and two tet operators, the first of which overlaps the promoter for tetR and the second of which overlaps the promoter being studied [Ptet(O)2 in Fig. 1]. This Ptet system has been used successfully to control gene expression in many Gram-positive bacteria, including B. subtilis (14), Staphylococcus aureus (3), Streptococcus mutans (42), and Streptococcus intermedius (27), and has even been used to control Gram-positive bacterial gene expression during animal infections (3, 13, 21).

Fig. 1.

Fig. 1.

Diagrams of Ptet-gusA fusions. The plasmid pEU9705 contains the Ptet(O)2 cassette, which includes the gene tetR (encoding the repressor) with its RBS followed by two tet operators (each has the sequence ACTCTATCATTGATAGAGT). The first tet operator overlaps the promoter for tetR, and the second overlaps the promoter for gusA. The distance between these two operators is 66 nt. The gusA gene has the consensus RBS (AGGAGG). pEU9711 is similar to pEU9705 but has an additional tetO inserted 14 nt after the first two operators [Ptet(O)3 cassette]. pEU9708 is the same as pEU9705 but has the internal region of tetR deleted. Promoters are designated by bent arrows. O, tetO. Note that the diagrams are not drawn to scale.

The system with two tet operators can be induced >50-fold by addition of the inducer in B. subtilis, but it shows expression even in the absence of the inducer (14). To eliminate expression in the absence of inducer, a third tetO was inserted following the first two tet operators (14) [Ptet(O)3 in Fig. 1]. Although this version of the tet cassette has no detectable expression in the absence of inducer, the highest level of induction achieved with it is at least 20 times lower than that for the induced double-tetO system (14). We therefore tried both the two- and three-operator Ptet cassettes for use in GAS.

An alternative to regulation at the level of transcription by an inducible promoter is use of a riboswitch, which takes advantage of the universal bacterial conservation of translational machinery. A riboswitch consists of a cis-acting mRNA domain that alters its conformation to allow ribosome binding in response to the intracellular concentration of a small molecule. Recently, Topp et al. (41) constructed a synthetic riboswitch responsive to the small molecule theophylline and showed that this riboswitch can be regulated in many different bacteria, both Gram negative and Gram positive. When this riboswitch was used in GAS in conjunction with a very strong promoter on a plasmid, a reporter showed very little expression in the absence of theophylline, while in the presence of this molecule, an increase in the reporter gene product of at least 50-fold was seen (41). Because this riboswitch appears to be active in GAS, at least on a plasmid, we also tested its use in this work.

We selected the following three candidate genes in GAS for inactivation by use of variants of Ptet constructs: rnjA, encoding RNase J1, and rnjB, encoding RNase J2, which we previously showed are essential in GAS by using a chromosomally inserted Ptet(O)3 construct (5); and hlp, which encodes the histone-like DNA-binding protein Hlp. Unlike the RNases, histone-like proteins are among the most abundant in bacteria, with about 60,000 molecules per cell in E. coli (1) and in B. subtilis (12, 36). Hlp serves as a DNA chaperone, folding and compacting DNA by binding to it with little nucleotide sequence specificity (10). This process affects transcription of genes and thus is important in regulating gene expression (9). Although nonessential in the Gram-negative bacterium E. coli, the Hlp homolog is essential for growth of many other bacteria, including B. subtilis (29), Deinococcus radiodurans (30), and Streptococcus intermedius (27). GAS strains carry a homolog of Hlp that was identified as the primary phosphorylation target of the serine threonine kinase (Stk) of this organism (22). Because Stk affects the GAS transcriptome (our unpublished work), we wished to delete hlp to examine its role in regulation by Stk. We were unable to delete hlp, so we surmised that it might be essential for growth of GAS as well.

In this work, we compared expression in GAS from different variants of Ptet and tested conditional activation of hlp from both Ptet(O)2 and Ptet(O)3. We also tested inactivation of hlp by expressing its antisense RNA from Ptet(O)2 on a plasmid. In addition, we compared expression of hlp from these three constructs with its production under the control of a synthetic riboswitch that we engineered into the chromosome to replace the native ribosome binding site. We concluded that the use of Ptet may be appropriate in specific situations, but limitations of its dynamic range preclude its universal use. On the other hand, the theophylline-regulated riboswitch can be used in this important human pathogen to study genes that encode proteins required in large quantities as well as those that are essential for growth.

MATERIALS AND METHODS

Bacterial growth conditions.

GAS strains MGAS315 (serotype M3) (4), JRS4 (serotype M6) (37), MGAS2221 (serotype M1) (38), and their derivatives were grown in Todd-Hewitt medium with 0.2% yeast extract (THY) at 37°C. To determine optical density without admitting extra oxygen, the cultures were grown in stoppered side-arm flasks and cell growth was monitored using a Klett-Summerson photoelectric colorimeter with a red filter. E. coli Top10 cells (Invitrogen), used for cloning, were grown in LB medium. For E. coli cultures, concentrations of antibiotics were as follows: spectinomycin, 50 μg/ml; kanamycin, 50 μg/ml; and chloramphenicol, 20 μg/ml. For GAS cultures, antibiotics were used at the following concentrations: spectinomycin, 100 μg/ml; kanamycin, 200 μg/ml; and chloramphenicol, 5 μg/ml.

To quantify Hlp RNA and protein, overnight cultures grown in THY, with or without 500 ng/ml anhydrotetracycline (AHT), were diluted 1/20 in prewarmed THY broth containing the same concentration of AHT, and growth was monitored in a colorimeter. When cultures reached mid-exponential phase, two aliquots were used, one to harvest RNA for quantitation of message and antisense RNA and the other for protein determination.

Construction of Ptet-gusA fusion plasmids. (i) pEU9705.

A fragment containing the inducible promoter (Ptet) and the tet repressor (tetR) was amplified from plasmid pTetE (42), and the gusA (β-glucuronidase) reporter gene was amplified from pJRS462 (16). These two fragments were fused by overlapping PCR and cloned into pJRS9508 (2), a derivative of the low-copy-number stable GAS plasmid pREG696 (15), to create pEU9705 (Fig. 1).

(ii) pEU9708.

The tet repressor was deleted from pEU9705 by use of a QuikChange site-directed mutagenesis kit (Agilent Technologies) to amplify the entire pEU9705 plasmid minus 660 bp within tetR, creating pEU9708 (Fig. 1).

(iii) pEU9711.

The gusA reporter amplified from pEU9703 and the Ptet(O)3 promoter with the Tet repressor region amplified from pEU8518 (5) were fused by overlapping PCR, and the fusion was inserted into pREG696 (15) to create pEU9711 (Fig. 1). The plasmids generated, pEU9705, pEU9708, and pEU9711, were electroporated into JRS4, and transformants were selected on THY plates containing spectinomycin.

Construction of inducible RNase J1 and RNase J2 mutants.

To generate strains JRS7314 [Ptet(O)2 rnjA in MGAS315] and JRS7315 [Ptet(O)2 rnjB in MGAS315], plasmids pEU8512 and pEU8510 (5) were linearized and electroporated separately into GAS strain MGAS315. The double-crossover transformants in GAS were selected in the presence of AHT (25 ng/ml) and chloramphenicol for the rnjA mutant or kanamycin for the rnjB mutant. The final result was the chromosomal integration of the Ptet(O)2 cassette in front of the ATG translation start codon of the gene for RNase J1 or RNase J2.

Construction of inducible Hlp mutants using Ptet.

Two fragments, one containing the region upstream of hlp and another containing a region that included hlp and the sequence downstream of hlp, were amplified from JRS4 genomic DNA in separate PCRs. The Ptet(O)2 cassette was amplified from pEU8512, and the Ptet(O)3 cassette was amplified from pEU8517 (5). The two hlp fragments were fused with either Ptet cassette fragment by overlapping PCR, cloned into pCR-XL-TOPO (Invitrogen), and transformed into strain MGAS2221 to generate the inducible hlp mutant strains JRS2514 and JRS2518 (see Fig. 4A) as described for the RNase J1 mutant.

Fig. 4.

Fig. 4.

Diagrams of Hlp conditional mutants. (A) Chromosomal mutants. The tetracycline-inducible mutants for Hlp contained the Ptet cassettes inserted directly in front of the ATG translation start codon for hlp. Spy numbers are from strain MGAS5005, whose sequence is identical in this region to that of MGAS2221 (39). (B) Plasmid expressing inducible hlp antisense RNA and control plasmid without hlp. (C) Plasmid expressing inducible hlp antisense RNA with transcriptional terminators flanking the cloned Ptet(O)2 hlp fragment. These diagrams are not drawn to scale. Bent arrow, promoter; lollipop, transcription terminator; O, tetO.

To generate pJRS7555, which expresses hlp antisense RNA under the control of the Ptet(O)2 promoter, the fragment containing hlp (including 17 nucleotides upstream of the hlp translation start codon and 282 nucleotides beyond the hlp stop codon) was amplified by PCR, using JRS4 genomic DNA as a template. The generated fragment was cloned in place of gusA in plasmid pEU9705 (Fig. 1), in the antisense orientation. The fragment containing Ptet(O)2 and the antisense hlp sequence was then moved from this plasmid to the high-copy-number plasmid pLZ12Spec (19) (see Fig. 4B).

To construct plasmid pJRS8334, which contains the Ptet(O)2 promoter with no gene expressed from it, pJRS7555 was digested to remove the antisense hlp fragment and then religated (see Fig. 4B).

To generate pJRS7559, a plasmid with terminators surrounding the region expressing the hlp antisense sequence under the control of the Ptet(O)2 promoter, the fragment containing Ptet(O)2 and the antisense hlp sequence was recloned from plasmid pJRS7555 into plasmid pTL61t (26) to produce pEU8335. The fragment containing Ptet(O)2 and the antisense hlp sequence surrounded by terminators was amplified from pEU8335 and cloned into pLZ12 (pLZ12 is pNZ12 [8] with a multiple cloning site) (obtained from B. Chassy) to generate pJRS7559 (see Fig. 4C).

Insertion of a riboswitch to control expression of Hlp.

To generate JRS2653 (in which translation of Hlp is controlled by a riboswitch), five DNA fragments were isolated using PCR: a fragment upstream of the hlp promoter region from MGAS2221 chromosomal DNA, a fragment carrying the chloramphenicol resistance gene from pLZ12, the hlp promoter region from MGAS2221, riboswitch E (41), and a region beginning with the start codon of Hlp and including the hlp gene and sequences downstream of hlp from MGAS2221. These five DNA fragments were fused in the order described above, and the resulting fragment was cloned into pCR-XL-TOPO (Invitrogen), the plasmid was linearized, and the DNA was electroporated into MGAS2221. Double-crossover transformants in GAS were selected in the presence of 2 mM theophylline and chloramphenicol. The correct insertion of the riboswitch was confirmed by sequencing.

β-Glucuronidase assay.

Overnight cultures grown in THY broth with spectinomycin were washed at room temperature and diluted 1/20 in prewarmed THY containing different concentrations of doxycycline or anhydrotetracycline as described in Results and Discussion. Aliquots of log-phase cultures were pelleted and resuspended in ice-cold Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, and 1 mM MgSO4). The cells were lysed by vortexing with glass beads (lysing matrix B; MP Biochemicals) for 10 min at the highest setting at 4°C. Debris was removed by centrifugation, and the supernatant was transferred to a clean tube at 4°C. Kinetic GusA assays were performed as described previously (11). GusA activity was normalized to the amount of total protein determined by the Pierce bicinchoninic acid (BCA) protein microassay.

RNA preparation and analysis.

RNA was prepared by the CsCl method as described previously (5). To quantify the amounts of rnjA, rnjB, and proS transcripts, we used real-time reverse transcription-PCR (RT-PCR) with a One Step iScript SYBR green kit (Bio-Rad). Controls and normalization of data were performed as described previously (35).

To quantify the amounts of hlp sense and antisense transcripts separately, a two-step real-time RT-PCR method was used. First, we used the avian myeloblastosis virus (AMV) reverse transcriptase (Promega) and either the reverse primer to generate cDNA from the hlp sense transcript or the forward primer to generate cDNA from the hlp antisense RNA. Following cDNA synthesis, the reverse transcriptase was inactivated by incubation at 95°C for 10 min. In the second step, cDNA was quantified by real-time PCR. The method for Northern blots to detect rnjB transcripts was described previously (5).

Western blot analysis of Hlp.

Mid-exponential-phase cells were resuspended in lysin buffer A (50 mM NH4OAc, pH 6.2, 10 mM CaCl2, and 1 mM dithiothreitol [DTT]) to which recombinant lysin from bacteriophage B30 of Streptococcus agalactiae (34) was added to a concentration of 200 U/ml. The cells were incubated at 30°C for 30 min with shaking at 700 rpm (Eppendorf Thermoblock) and boiled for 10 min in SDS-PAGE sample buffer. Proteins were resolved in a Bis-Tris 4 to 12% acrylamide gel (Invitrogen) with morpholineethanesulfonic acid (MES) running buffer (Invitrogen), transferred to nitrocellulose membranes (Bio-Rad), and incubated with anti-S. pyogenes Hlp antibody (obtained from V. Pancholi [22]). Bands were detected using alkaline phosphatase conjugated to goat anti-rabbit IgG (Sigma).

Effect of theophylline on growth.

Overnight cultures of strains MGAS2221 and JRS2653, grown in THY broth plus 2 mM theophylline and THY broth plus 2 mM theophylline and chloramphenicol, respectively, were washed once to remove the theophylline and counted in a Petroff-Hauser chamber. Cells were resuspended to the same cell number, and 10-fold serial dilutions were spotted on THY agar with and without 2 mM theophylline. Following incubation at 37°C for 24 h, plates were photographed.

RESULTS AND DISCUSSION

Ptet with two or three operators can be induced to different levels in GAS.

For quantitative comparison of the expression of the tetracycline-inducible promoter Ptet, we constructed transcriptional fusions to the reporter gene gusA on a low-copy-number plasmid that is maintained stably in GAS. To compare the effects of two versus three operators, we constructed two different plasmids, each of which contained the gene for the repressor of Ptet (tetR) with its own promoter and its native RBS. In one plasmid, pEU9705, this was followed by two tet operators (O2), and in the other plasmid, pEU9711, by three operators (O3). To determine the induction level in the complete absence of repression, we constructed plasmid pEU9708, which is identical to pEU9705 but lacks tetR (Fig. 1). These plasmids were electroporated separately into strain JRS4 to study the induction of Ptet in GAS.

We then identified a concentration of inducer sufficient to activate Ptet without inhibiting GAS growth. We investigated the effects of two different inducers, doxycycline and AHT, both of which have been used for Ptet activation in other bacteria (13, 25, 27, 42), on growth of the GAS strain JRS4/pEU9705 in liquid medium. We found that at the lowest concentration sufficient to produce detectable activation of Ptet (≥2 ng/ml), doxycycline inhibited cell growth (data not shown). However, AHT at concentrations as high as 500 ng/ml had no effect on the growth of GAS in liquid culture (Fig. 2). Therefore, unless otherwise noted, we used this concentration of AHT for induction.

Fig. 2.

Fig. 2.

Effect of AHT on growth of GAS. Strain JRS4/pEU9705 was grown at 37°C in THY broth containing the indicated concentrations of AHT. ⋄, 0 ng/ml; ▪, 500 ng/ml; ▴, 750 ng/ml; •, 1,000 ng/ml.

We found that Ptet(O)2 was induced about 5-fold in JRS4/pEU9705 (Table 1), suggesting that this promoter would be useful for further studies. However, in JRS4 with the plasmid lacking the tet repressor (pEU9708), GusA activity was >3-fold higher than that in the induced strain carrying plasmid pEU9705 (Table 1). This indicates that the highest concentration of AHT that could be used without inhibiting cell growth, 500 ng/ml, was inadequate for complete induction of Ptet(O)2. Furthermore, there was significant Gus activity expressed from Ptet(O)2 in the absence of inducer, which might limit the value of this construct in genetic analyses. In the Ptet(O)3 construct, pEU9711, Gus activity was undetectable in the absence of inducer. However, induction from this construct was not as great (Table 1). In summary, both promoter constructs [Ptet(O)2 and Ptet(O)3] demonstrated regulated activity in GAS, and although both had disadvantages as well as advantages, both can be used to control expression of genes in this bacterium.

Table 1.

β-Glucuronidase activities of strains in this study

Strain description Plasmid β-Glucuronidase activity (GU/mg protein)
0 ng/ml AHT 500 ng/ml AHT
Ptet(O)2gusA pEU9705 303 ± 27 1,446 ± 3
Ptet(O)3gusA pEU9711 <5 113 ± 47
ΔtetR Ptet(O)2gusA pEU9708 4,310 ± 268 NDa
a

ND, not determined.

Use of Ptet in the chromosome of GAS for expression of essential genes.

We recently demonstrated that Ptet(O)3 can be used successfully to control chromosomal expression of the genes encoding RNase J1 (rnjA) and RNase J2 (rnjB) in GAS strain MGAS315, the strain that we used for mRNA decay studies (5). Here we determined whether the two-operator construct Ptet(O)2 could be used in the chromosome of GAS for conditional expression of essential genes, since it was inducible to a higher level than Ptet(O)3. We inserted the cassette containing Ptet(O)2 in front of the ATG translation start for the rnjA or rnjB gene in the chromosome of MGAS315 as described in Materials and Methods. The generated strains, JRS7314 [Ptet(O)2 rnjA] and JRS7315 [Ptet(O)2 rnjB], contained an antibiotic resistance gene for selection (chloramphenicol for rnjA and kanamycin for rnjB), following tetR and separated from it by transcriptional terminators (5). This Ptet cassette also contained a strong ribosome binding site (AGGAGG) to drive expression of rnjA or rnjB. As reported previously (5), neither of the strains with three operators grew without inducer, but both were viable in the presence of AHT. However, we now report that for both J1 and J2, expression from Ptet(O)2 was high enough in the absence of induction to allow growth of GAS (data not shown). Thus, in this context, it was preferable to reduce constitutive expression from Ptet at the cost of reducing the amount of expression upon induction.

To quantify the amounts of rnjA and rnjB transcripts from Ptet(O)3 in each of these strains, we used quantitative real-time RT-PCR (Q-RT-PCR). We used strains JRS7316 and JRS7317/pJRS9508 [with Ptet(O)3 rnjA and Ptet(O)3 rnjB, respectively] grown with 25 ng/ml AHT (“induced”), which was more than sufficient to restore growth of the mutants to wild-type rates, and with 0.1 ng/ml AHT (“uninduced”), which allowed some growth of the mutants (5). We found that the amounts of rnjA and rnjB transcripts were 3- to 6-fold greater following induction than in the uninduced strain (Fig. 3A). This is much less than the induction we observed for the gusA reporter on a plasmid (Table 1). Quantitation of rnjB transcripts in a Northern blot corroborated the results from Q-RT-PCR, i.e., induction produced a 5-fold increase in the amount of transcripts (Fig. 3B). In addition, Northern blot analysis of the rnjB operon showed that all three transcripts (two of which included downstream genes) (5) appeared to be full length. Thus, Ptet(O)3 seems a better choice for inactivation and regulation of the RNase J genes, which code for essential enzymes in GAS.

Fig. 3.

Fig. 3.

Amounts of transcripts for RNase J1 and RNase J2 in the conditional mutants and the wild-type strain. (A) Real-time RT-PCR analysis of transcript amounts of rnjA in strain JRS7316 [Ptet(O)3 rnjA] and of rnjB in strain JRS7317/pJRS9508 [Ptet(O)3 rnjB]. The conditional mutants were grown with 0.1 ng/ml of AHT (white bars) or with 25 ng/ml of AHT (black bars). Averages ± standard deviations relative to the amount of gyrA are presented. Each bar represents four technical replicates from two independent cultures. (B) Northern blot analysis with 5 μg of total RNA for the strain JRS7317/pJRS9508 [Ptet(O)3 rnjB] grown with 0.1 ng/ml of AHT (−) or with 25 ng/ml AHT (+). The probe was specific for rnjB.

Use of Ptet to regulate expression of hlp.

Because hlp is essential for growth in other bacteria, including S. intermedius (27), and because we were unable to delete it, we anticipated that it might also be required in GAS. To determine whether this was the case, we inserted the Ptet cassettes into the chromosome in front of hlp, following the same strategy as that used for the RNase J genes (Fig. 4). The cassette containing the chloramphenicol resistance gene, tetR, and Ptet(O)2 was integrated in front of the translation start ATG for hlp in the chromosome of the GAS strain MGAS2221, a serotype M1 strain, to generate JRS2514, and the same strategy with Ptet(O)3 was used to generate JRS2518 (Fig. 4A). To evaluate the effect of induction of each tet cassette on expression of Hlp, we used Western blotting (Fig. 5). This showed that induction with AHT increased the amounts of Hlp in the Ptet strains, while AHT had no effect on the amount of Hlp in the wild-type parental strain. Although the amount of Hlp in the absence of induction in the Ptet(O)3 strain was significantly lower than that in the Ptet(O)2 strain, as expected, it was still significant and allowed normal growth (data not shown).

Fig. 5.

Fig. 5.

Western blot showing the expression of Hlp. Total cell lysates from log-phase cultures grown without AHT (−) and in the presence of 500 ng/ml AHT (+) were resolved in a Bis-Tris 4 to 12% acrylamide gel (Invitrogen). Bands for Hlp were detected using rabbit anti-Hlp antiserum. MW, Novex Sharp standard; molecular sizes are shown to the left of the figure. MGAS2221, wild type; JRS2514, Ptet(O)2 hlp; JRS2518, Ptet(O)3 hlp.

Use of Ptet to produce hlp antisense RNA.

Since the constitutive level of Hlp even in the Ptet(O)3 strain seemed likely to be too high to be useful, we attempted an antisense approach to reduce Hlp expression further. We constructed pJRS7555 by removing the native promoter and inserting Ptet(O)2 oriented to produce antisense RNA for hlp (Fig. 4B). Although the addition of AHT to MGAS2221/pJRS7555 or strain JRS4/pLZ12spec prevented or reduced growth on plates (Fig. 6A and B), strain MGAS2221, containing the control plasmid pJRS8334 (Fig. 4B) in which the hlp gene was deleted, also showed sensitivity to addition of AHT (Fig. 6C). Therefore, no conclusion about the essentiality of Hlp in GAS can be drawn from this experiment.

Fig. 6.

Fig. 6.

Effect of Hlp on growth on THY plates. Tenfold serial dilutions of overnight cultures were spotted on plates with and without AHT (500 ng/ml). The plates were incubated at 37°C with 5% CO2 for 18 h (A) or for 23 h (B and C) and then photographed. Plasmid pJRS7555 expresses antisense RNA for hlp from the promoter Ptet(O)2, pJRS8334 contains Ptet(O)2 but no hlp, and pLZ12Spec is the empty vector.

The effect of pJRS8334 on growth of GAS suggested that a transcript resulting from readthrough from the induced Ptet into the plasmid was detrimental to GAS growth. To test this idea, we inserted multiple terminators upstream of tetR and downstream of hlp in the Ptet(O)2 hlp antisense construct to give plasmid pJRS7559 (Fig. 4C) as a source of hlp antisense RNA. We evaluated the effect of AHT induction on production of both sense and antisense hlp RNAs and normalized these to the amount of proS message. Quantitation of the antisense hlp RNA in MGAS2221/pJRS7559 showed an increase of 9-fold following AHT induction, while the effect of AHT in MGAS2221 with the empty vector (pLZ12) was <2-fold, suggesting that this approach was effective. In agreement with this, the sense hlp transcript in MGAS2221/pJRS7559 decreased 7-fold with induction, while AHT had little effect on the sense hlp transcript in MGAS2221/pLZ12. However, although induction of the hlp antisense transcript was successful, it had very little effect on the amount of Hlp protein present (Fig. 7, compare lanes 1 and 2) and no effect on cell growth (data not shown). The strain producing the least Hlp protein was uninduced JRS2518, which had Ptet(O)3 inserted into the chromosome in front of hlp (Fig. 7, lane 3).

Fig. 7.

Fig. 7.

Western blot showing the expression of Hlp in the hlp chromosomal mutant and the strain expressing antisense RNA for hlp. Strains MGAS2221 (wild type) and JRS2518 [Ptet(O)3 hlp] were grown without AHT (−), and strain MGAS2221/pJRS7559 [Ptet(O)2 hlp antisense] was grown in the presence of 500 ng/ml AHT (+). Total cell lysates prepared from the three strains were resolved in a Bis-Tris 4 to 12% acrylamide gel (Invitrogen). Hlp was detected using rabbit anti-Hlp antiserum.

Use of a riboswitch shows that Hlp is essential for GAS growth.

Because we were unable to use Ptet in any configuration to generate a significant decrease in the amount of Hlp protein below that in the wild type, an alternative approach was attempted. We used a newly described synthetic riboswitch (41) to regulate translation of this gene. In this riboswitch system, the RBS is occluded by spontaneous folding of the mRNA. The RBS is freed to bind ribosomes and translate the message when a small-molecule ligand, theophylline, is added to the medium. To avoid the use of plasmids, we inserted the riboswitch directly upstream of the hlp open reading frame in the chromosome of strain MGAS2221 to generate strain JRS2653, which was isolated and maintained in the presence of theophylline. To determine whether theophylline was required for growth of JRS2653, in which Hlp translation was under the control of the riboswitch, overnight cultures of JRS2653 and the wild-type strain MGAS2221 grown in the presence of theophylline were washed to remove the theophylline and diluted to the same cell number. Dilutions of both strains were spotted onto plates with and without theophylline and incubated for 24 h at 37°C. As shown in Fig. 8, theophylline was required for growth of JRS2653, demonstrating that in GAS, hlp is an essential gene. As might be expected for a gene encoding an essential protein, extended periods of incubation of JRS2653 in the absence of theophylline led to outgrowth of mutants (data not shown).

Fig. 8.

Fig. 8.

Hlp is required for growth of GAS. Overnight cultures of strain JRS2653, expressing Hlp under the control of the riboswitch, and its parent strain, MGAS2221, were pelleted, and the pellets were washed with saline to remove the theophylline. The two cultures were adjusted to the same cell number, and serial 10-fold dilutions (columns) were spotted in duplicate (rows) on THY plates with 2 mM theophylline and without theophylline. Plates were incubated at 37°C for 24 h.

Conclusions.

To evaluate the role of any specific gene in the pathophysiology of GAS, tools that allow the experimenter to regulate gene expression are required. We evaluated four approaches to achieve this goal: we expressed genes under the control of two variants of the inducible Ptet promoter, we used antisense RNA to reduce expression, and we used a synthetic riboswitch to control translation in response to a small-molecule ligand. We found that the Ptet cassette with three operators was effective for study of RNase J1 (rnjA) and RNase J2 (rnjB), which are expressed at low levels, while the same cassette with two operators had an uninduced background level that was too high for studies of proteins required in very small amounts. However, the two-operator tet cassette can be induced to a higher level than the three-operator cassette and thus might be useful in the antisense configuration. We found that although the amount of the sense transcript for hlp in a cell was significantly reduced when antisense transcript for hlp was expressed under the control of Ptet(O)2, there was still too much Hlp protein to determine whether Hlp is required for GAS growth. The last method we evaluated was use of a newly developed riboswitch in which the small-molecule theophylline controls translation of a protein by regulating the access of ribosomes to the ribosome binding site. The addition of theophylline led to at least a 50-fold increase in the amount of protein translated from the riboswitch (41), and this was sufficient for expression of Hlp in the amount required for GAS growth. Of all the gene regulation methods tested, only the riboswitch, which has very low background expression in the absence of the ligand (41), reduced the amount of the abundant Hlp protein sufficiently to demonstrate that Hlp is essential for growth of GAS. We anticipate that in future studies several of these methods may be combined to allow investigation of several genes simultaneously. In addition, the tet cassette has already been used in murine infection models (3, 13, 17, 20, 21, 28), and future work will determine whether the riboswitch can also be used in animal models of infection.

ACKNOWLEDGMENTS

We are grateful to V. Pancholi for his generous gift of anti-Hlp antiserum. We are also grateful to C. Reynoso and J. Gallivan for the riboswitch.

This work was supported in part by NIH grant AI20723.

Footnotes

Published ahead of print on 29 April 2011.

REFERENCES

  • 1. Ali Azam T., Iwata A., Nishimura A., Ueda S., Ishihama A. 1999. Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid. J. Bacteriol. 181:6361–6370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Barnett T. C., Bugrysheva J. V., Scott J. R. 2007. Role of mRNA stability in growth phase regulation of gene expression in the group A Streptococcus. J. Bacteriol. 189:1866–1873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bateman B. T., Donegan N. P., Jarry T. M., Palma M., Cheung A. L. 2001. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect. Immun. 69:7851–7857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Beres S. B., et al. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. U. S. A. 99:10078–10083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bugrysheva J. V., Scott J. R. 2010. The ribonucleases J1 and J2 are essential for growth and have independent roles in mRNA decay in Streptococcus pyogenes. Mol. Microbiol. 75:731–743 [DOI] [PubMed] [Google Scholar]
  • 6. Carapetis J. R., Steer A. C., Mulholland E. K., Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685–694 [DOI] [PubMed] [Google Scholar]
  • 7. Cunningham M. W. 2008. Pathogenesis of group A streptococcal infections and their sequelae. Adv. Exp. Med. Biol. 609:29–42 [DOI] [PubMed] [Google Scholar]
  • 8. de Vos W. M. 1986. Genetic improvement of starter streptococci by the cloning and expression of the gene coding for a non-bitter proteinase, p. 465–472 In Magnien E. (ed.), Biomolecular engineering in the European community: achievements of the research programme (1982-86): final report. Martinus-Nijhoff, Lancaster, United Kingdom [Google Scholar]
  • 9. Dorman C. J., Deighan P. 2003. Regulation of gene expression by histone-like proteins in bacteria. Curr. Opin. Genet. Dev. 13:179–184 [DOI] [PubMed] [Google Scholar]
  • 10. Drlica K., Rouviere-Yaniv J. 1987. Histonelike proteins of bacteria. Microbiol. Rev. 51:301–319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Eichenbaum Z., et al. 1998. Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl. Environ. Microbiol. 64:2763–2769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Fernandez S., Alonso J. C. 1999. Bacillus subtilis sequence-independent DNA-binding and DNA-bending protein Hbsu negatively controls its own synthesis. Gene 231:187–193 [DOI] [PubMed] [Google Scholar]
  • 13. Gandotra S., Schnappinger D., Monteleone M., Hillen W., Ehrt S. 2007. In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat. Med. 13:1515–1520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Geissendorfer M., Hillen W. 1990. Regulated expression of heterologous genes in Bacillus subtilis using the Tn10 encoded tet regulatory elements. Appl. Microbiol. Biotechnol. 33:657–663 [DOI] [PubMed] [Google Scholar]
  • 15. Grady R., Hayes F. 2003. Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol. Microbiol. 47:1419–1432 [DOI] [PubMed] [Google Scholar]
  • 16. Gusa A. A., Scott J. R. 2005. The CovR response regulator of group A Streptococcus (GAS) acts directly to repress its own promoter. Mol. Microbiol. 56:1195–1207 [DOI] [PubMed] [Google Scholar]
  • 17. Hernandez-Abanto S. M., Woolwine S. C., Jain S. K., Bishai W. R. 2006. Tetracycline-inducible gene expression in mycobacteria within an animal host using modified Streptomyces tcp830 regulatory elements. Arch. Microbiol. 186:459–464 [DOI] [PubMed] [Google Scholar]
  • 18. Hillen W., Berens C. 1994. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48:345–369 [DOI] [PubMed] [Google Scholar]
  • 19. Husmann L. K., Scott J. R., Lindahl G., Stenberg L. 1995. Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect. Immun. 63:345–348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Ji Y., Marra A., Rosenberg M., Woodnutt G. 1999. Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J. Bacteriol. 181:6585–6590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ji Y., et al. 2001. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293:2266–2269 [DOI] [PubMed] [Google Scholar]
  • 22. Jin H., Pancholi V. 2006. Identification and biochemical characterization of a eukaryotic-type serine/threonine kinase and its cognate phosphatase in Streptococcus pyogenes: their biological functions and substrate identification. J. Mol. Biol. 357:1351–1372 [DOI] [PubMed] [Google Scholar]
  • 23. Kaplan E. L., Johnson D. R. 2001. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 108:1180–1186 [DOI] [PubMed] [Google Scholar]
  • 24. Kuipers O. P., Beerthuyzen M. M., de Ruyter P. G., Luesink E. J., de Vos W. M. 1995. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270:27299–27304 [DOI] [PubMed] [Google Scholar]
  • 25. Lathem W. W., Price P. A., Miller V. L., Goldman W. E. 2007. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315:509–513 [DOI] [PubMed] [Google Scholar]
  • 26. Linn T., St. Pierre R. 1990. Improved vector system for constructing transcriptional fusions that ensures independent translation of lacZ. J. Bacteriol. 172:1077–1084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Liu D., et al. 2008. The essentiality and involvement of Streptococcus intermedius histone-like DNA-binding protein in bacterial viability and normal growth. Mol. Microbiol. 68:1268–1282 [DOI] [PubMed] [Google Scholar]
  • 28. Loessner H., et al. 2009. Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect. 11:1097–1105 [DOI] [PubMed] [Google Scholar]
  • 29. Micka B., Marahiel M. A. 1992. The DNA-binding protein HBsu is essential for normal growth and development in Bacillus subtilis. Biochimie 74:641–650 [DOI] [PubMed] [Google Scholar]
  • 30. Nguyen H. H., et al. 2009. The essential histone-like protein HU plays a major role in Deinococcus radiodurans nucleoid compaction. Mol. Microbiol. 73:240–252 [DOI] [PubMed] [Google Scholar]
  • 31. Olsen R. J., Musser J. M. 2010. Molecular pathogenesis of necrotizing fasciitis. Annu. Rev. Pathol. 5:1–31 [DOI] [PubMed] [Google Scholar]
  • 32. Pichichero M. E. 1998. Group A beta-hemolytic streptococcal infections. Pediatr. Rev. 19:291–302 [DOI] [PubMed] [Google Scholar]
  • 33. Pichichero M. E., Casey J. R. 2007. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol. Head Neck Surg. 137:851–857 [DOI] [PubMed] [Google Scholar]
  • 34. Pritchard D. G., Dong S., Baker J. R., Engler J. A. 2004. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150:2079–2087 [DOI] [PubMed] [Google Scholar]
  • 35. Roberts S. A., Scott J. R. 2007. RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol. Microbiol. 66:1506–1522 [DOI] [PubMed] [Google Scholar]
  • 36. Schmid M. B. 1990. More than just “histone-like” proteins. Cell 63:451–453 [DOI] [PubMed] [Google Scholar]
  • 37. Scott J. R., Guenthner P. C., Malone L. M., Fischetti V. A. 1986. Conversion of an M− group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J. Exp. Med. 164:1641–1651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Sumby P., et al. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved in multiple horizontal gene transfer events. J. Infect. Dis. 192:771–782 [DOI] [PubMed] [Google Scholar]
  • 39. Sumby P., Whitney A. R., Graviss E. A., DeLeo F. R., Musser J. M. 2006. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2:e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Tart A. H., Walker M. J., Musser J. M. 2007. New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol. 15:318–325 [DOI] [PubMed] [Google Scholar]
  • 41. Topp S., et al. 2010. Synthetic riboswitches that induce gene expression in diverse bacterial species. Appl. Environ. Microbiol. 76:7881–7884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Wang B., Kuramitsu H. K. 2005. Inducible antisense RNA expression in the characterization of gene functions in Streptococcus mutans. Infect. Immun. 73:3568–3576 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES